FindTrial
Sign In

Study of tumour markers in pterygium

Study of Biomarkers P53,Bcl-2,Ki67 and VEGF in pterygium

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/01/039609
Enrollment
17
Registered
2022-01-20
Start date
Unknown
Completion date
Unknown
Last updated
2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H110- Pterygium of eye

Interventions

None listed

Sponsors

Maulana Azad Medical College And AssociatedGURU NANAK EYE CENTRE
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All cases of Primary Pterygium presenting to Cornea clinic , GURU NANAK EYE CENTRE, New Delhi

Exclusion criteria

Exclusion criteria: Children younger than 10 years, Secondary pterygium,Recurrent pterygium,Any corneal opacity,Prior ocular trauma

Design outcomes

Primary

MeasureTime frame
Immunohistochemical expression of biomarkers P53, BCL2,Ki67, and VEGF in primary pterygium and normal conjunctivaTimepoint: AT BASELINE—

Secondary

MeasureTime frame
nilTimepoint: nil—

Countries

India

Contacts

Public ContactDrRitu Arora

MAULANA AZAD MEDICAL COLLEGE and associated GURU NANAK EYE CENTRE

dr_rituarora@yahoo.com9968604331

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026